CSIMarket Company Name, Ticker, Industry, else..


American Bio Medica Corporation  (ABMC)
Other Ticker:  
 

American Bio Medica Corporation

ABMC's Fundamental analysis



American Bio Medica's sales fell by -53.28 % in I. Quarter 2023 from the same quarter a year ago. Ranking at No. 3950

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -8.34 %

American Bio Medica realized net income compared to net loss a year ago in I. Quarter 2023

• More on ABMC's Growth


American Bio Medica
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 0.09 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.01.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.


• More on ABMC's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 72,600
 Net Income/Employee (TTM) $ 85,000
 Receivable Turnover (TTM) 9.91
 Tangible Book Value (Per Share $) -0.01

American Bio Medica
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 0.09 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.01.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.


• More on ABMC's Valuation

•  Market Capitalization (Millions $) 0
•  Shares Outstanding (Millions) 48
•  Employees 10
•  Revenues (TTM) (Millions $) 1
•  Net Income (TTM) (Millions $) 1
•  Cash Flow (TTM) (Millions $) 0
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 72,600
•  Net Income/Employee(TTM) $ 85,000
•  Receivable Turnover Ratio (TTM) 9.91
•  Tangible Book Value (Per Share $) -0.01

•  Market Capitalization (Millions $) 0
•  Shares Outstanding (Millions) 48
•  Employees 10
•  Revenues (TTM) (Millions $) 1
•  Net Income (TTM) (Millions $) 1
•  Cash Flow (TTM) (Millions $) 0
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 0.59
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.61
•  Inventory Turnover Ratio (TTM) -





American Bio Medica net profit margin of 1146.95 % is currently ranking no. 2 in Major Pharmaceutical Preparations industry, ranking no. 4 in Healthcare sector and number 27 in S&P 500.

• More on ABMC's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com